Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway

por Shao, Jingwei, Zheng, Guirong, Chen, Hongning, Liu, Jian, Xu, Aixiao, Chen, Fan, Li, Tao, Lu, Yusheng, Xu, Jianguo, Zheng, Ning, Jia, Lee
Publicado 2017

AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells

por Bing, Shaowei, Xiang, Senfeng, Xia, Zhimei, Wang, Yilong, Guan, Zhonghai, Che, Jinxin, Xu, Aixiao, Dong, Xiaowu, Cao, Ji, Yang, Bo, Wang, Jinhu, He, Qiaojun, Ying, Meidan
Publicado 2023